Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioblastoma × Physical Examination × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Suicidal Ideation 1 Stomach Ulcer 1 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Neoplasms 1 Motor Activity 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Li-Fraumeni Syndrome 1 Hyperandrogenism 1 Hamartoma Syndrome, Multiple 1 Glioblastoma 1 Gastrointestinal Hemorrhage 1 Gastrointestinal Diseases 1 Gastritis 1 Depression 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Bursitis 1 Breast Neoplasms 1

Interventions

Temozolomide 42 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Bevacizumab 12 Specimen Handling 11 Lomustine 11 Radiation 8 Cyclophosphamide 6 fludarabine 5 Nivolumab 4 Aminolevulinic Acid 4 olaparib 3 atezolizumab 3 Transurethral Resection of Bladder 3 Surgical Procedures, Operative 3 Ipilimumab 3 D2C7-(scdsFv)-PE38KDEL 3 regorafenib 2 fluciclovine F-18 2 contrast agent BR1 2 antisecretory factor 2 abemaciclib 2 Standard of Care 2 Restraint, Physical 2 Re-Irradiation 2 Radiation Dose Hypofractionation 2 Palliative Care 2 Oncolytic Virotherapy 2 ONC206 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07409584 2026-04-06

SHINE-GLIO

University Hospital, Essen

Depression, Glioblastoma, Suicidal Ideation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡